{"SPADE_UN_11656": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11656", "Peptide Name": "Cath-A", "Source": "Synthetic construct", "Family": "Derived from three-finger toxin", "Gene": "Not found", "Sequence": "KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF", "Sequence Length": 34, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.29392557] Gram-positive bacteria:MRSA PS-2 (MIC=64 μg/ml);Gram-negative bacteria, MRSA PS-7 (MIC=64 μg/ml), MRSA PS-18 (MIC=32 μg/ml), MRSA PS-45 (MIC=32 μg/ml), MRSA PS-46 (MIC=32 μg/ml), MRSA PS-50 (MIC=32 μg/ml), MRSA PS-59 (MIC=64 μg/ml), MRSA PS-70 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-106 (MIC=32 μg/ml), MRSA PS-131 (MIC=128 μg/ml), MRSA PS-139 (MIC=32 μg/ml), MRSA PS-162 (MIC=128 μg/ml), MRSA PS-165 (MIC=32 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=128 μg/ml);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli ATCC 51446 (MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=64 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=16 μg/ml)", "Hemolytic Activity": "[Ref.29392557] 0% haemolysis at 1.0 μg/ml, 0% haemolysis at 2.0 μg/ml, 0% haemolysis at 4.0 μg/ml, 0% haemolysis at 8.0 μg/ml, 0% haemolysis at 16.0 μg/ml, 0% haemolysis at 31.2 μg/ml, 2% haemolysis at 62.5 μg/ml, 4% haemolysis at 125.0 μg/ml, 15% haemolysis at 250.0 μg/ml, 23% haemolysis at 500.0 μg/ml, 53% haemolysis  at 1000.0 μg/ml against human red blood cells", "Cytotoxicity": "[Ref.29392557] The cell viability of HUVEC is 132%, 99% and 79%  at peptide concentrations of 35.5, 71 and 113 μg/ml .The cell viability of H9c2is 129%, 97%, and 80% at peptide concentrations of 35.5, 71, and 113 μg/ml .", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C207H354N60O39", "Mass": 4307.4, "PI": 12.0, "Net Charge": 17, "Hydrophobicity": -1.22, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria.", "Literature": [{"Title": "The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.", "Pubmed ID": "29392557", "Reference": "J Microbiol. 2018 Feb;56(2)128-137.", "Author": "Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29392557"}, {"Title": "The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus", "Pubmed ID": "", "Author": "Tajbakhsh M, Karimi A, Tohidpour A, Abbasi n, Fallah F, Akhavan MM"}], "Frequent Amino Acids": "KFR", "Absent Amino Acids": "ACDGHMNOQTUWY", "Basic Residues": 18, "Acidic Residues": 1, "Hydrophobic Residues": 13, "Polar Residues": 23, "Positive Residues": 18, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06372", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKSV"}, {"SPADE_ID": "SPADE_N_09466", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKSVK"}, {"SPADE_ID": "SPADE_N_09467", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKSVKK"}]}}}